Log in to save to my catalogue

Sulbactam–durlobactam for infections caused by Acinetobacter baumannii–calcoaceticus complex – Autho...

Sulbactam–durlobactam for infections caused by Acinetobacter baumannii–calcoaceticus complex – Autho...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2838240979

Sulbactam–durlobactam for infections caused by Acinetobacter baumannii–calcoaceticus complex – Authors' reply

About this item

Full title

Sulbactam–durlobactam for infections caused by Acinetobacter baumannii–calcoaceticus complex – Authors' reply

Publisher

United States: Elsevier Ltd

Journal title

The Lancet infectious diseases, 2023-08, Vol.23 (8), p.e275-e276

Language

English

Formats

Publication information

Publisher

United States: Elsevier Ltd

More information

Scope and Contents

Contents

Results from the ATTACK trial show the safety and efficacy of sulbactam–durlobactam for the treatment of hospital-acquired and ventilator-associated bacterial pneumonia caused by susceptible strains of ABC. Individual treatment approaches will need to be established on a case-by-case basis on the basis of the clinical condition of each patient, mic...

Alternative Titles

Full title

Sulbactam–durlobactam for infections caused by Acinetobacter baumannii–calcoaceticus complex – Authors' reply

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2838240979

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2838240979

Other Identifiers

ISSN

1473-3099

E-ISSN

1474-4457

DOI

10.1016/S1473-3099(23)00423-1

How to access this item